Research

There may never be a 'silver bullet' for COVID-19, WHO warns

Mon, 2020-08-03 09:43 — mike kraft

There may never be a 'silver bullet' for COVID-19, WHO warns The World Health Organization warned on Monday that, despite strong hopes for a vaccine, there might never be a "silver bullet" for COVID-19, and the road to normality would be long. Michael Shields U.S.

GENEVA (Reuters) - The World Health Organization warned on Monday that, despite strong hopes for a vaccine, there might never be a “silver bullet” for COVID-19, and the road to normality would be long.

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Situation Report

Read more about There may never be a 'silver bullet' for COVID-19, WHO warns
1 comment
Log in or register to post comments

Scientists Worry About Political Influence Over Coronavirus Vaccine Project

Mon, 2020-08-03 09:34 — mike kraft

In April, with hospitals overwhelmed and much of the United States in lockdown, the Department of Health and Human Services produced a presentation for the White House arguing that rapid development of a coronavirus vaccine was the best hope to control the pandemic.

“DEADLINE: Enable broad access to the public by October 2020,” the first slide read, with the date in bold.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Scientists Worry About Political Influence Over Coronavirus Vaccine Project
Log in or register to post comments

Next big COVID-19 treatment may be manufactured antibodies

Mon, 2020-08-03 09:12 — mike kraft

Next big COVID-19 treatment may be manufactured antibodies As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from a class of biotech therapies widely used against cancer and other disorders - antibodies designed specifically to attack this new virus. Deena Beasley U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Read more about Next big COVID-19 treatment may be manufactured antibodies
Log in or register to post comments

Do some people have protection against the coronavirus?

Sun, 2020-08-02 16:18 — mike kraft

Do some people have protection against the coronavirus? Why do some people get very sick and even die from Covid-19, while others show few if any symptoms? We know some of the big factors that put people at higher risk of having a severe course of disease, but could certain people actually have some type of protection? Dr. Sanjay Gupta and Andrea Kane, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Do some people have protection against the coronavirus?
Log in or register to post comments

A guide to the dozens of COVID-19 vaccines that are in development.

Sat, 2020-08-01 12:41 — mike kraft

Dozens of COVID-19 vaccines are in development. Here are the ones to follow. Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond. Science

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about A guide to the dozens of COVID-19 vaccines that are in development.
Log in or register to post comments

CDC: Children might play 'important role' in spreading COVID-19

Fri, 2020-07-31 19:04 — mike kraft

https://www.cdc.gov/mmwr/volumes/69/wr/mm6931e1.htm?s_cid=mm6931e1_w

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about CDC: Children might play 'important role' in spreading COVID-19
Log in or register to post comments

European drugmakers Sanofi and GSK strike $2.1 billion deal with U.S. for a coronavirus vaccine

Fri, 2020-07-31 09:15 — mike kraft

European drugmakers Sanofi and GSK strike $2.1 billion deal with U.S. for a coronavirus vaccine The contract is the largest yet from the U.S. government. Carolyn Y. Johnson Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about European drugmakers Sanofi and GSK strike $2.1 billion deal with U.S. for a coronavirus vaccine
Log in or register to post comments

XPrize to give $5 million to creator of cheap, fast COVID-19 testing

Thu, 2020-07-30 21:28 — mike kraft

XPrize to give $5 million to creator of cheap, fast COVID-19 testing Google and Amazon are backing it, among others. Shannon Connellan Mashable

Tech giants including Google and Amazon pledged support for a $5 million competition to accelerate cheap and fast COVID-19 testing in the U.S.

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Read more about XPrize to give $5 million to creator of cheap, fast COVID-19 testing
Log in or register to post comments

Children may carry coronavirus at high levels, study finds

Thu, 2020-07-30 21:06 — mike kraft

Children may carry coronavirus at high levels, study finds Infected children have at least as much of the coronavirus in their noses and throats as infected adults, according to the research. Indeed, children younger than age 5 may host up to 100 times as much of the virus in the upper respiratory tract as adults, the authors found. Apoorva Mandavilli chicagotribune.com

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Children may carry coronavirus at high levels, study finds
Log in or register to post comments

Old Vaccines May Stop the Coronavirus, Study Hints. Scientists Are Skeptical.

Thu, 2020-07-30 13:16 — mike kraft

Billions of dollars are being invested in the development of vaccines against the coronavirus. Until one arrives, many scientists have turned to tried-and-true vaccines to see whether they may confer broad protection, and may reduce the risk of coronavirus infection, as well.

Old standbys like the Bacille Calmette-Guerin tuberculosis vaccine and the polio vaccine appear to help train the immune system to respond to a broad variety of infections, including from bacteria, viruses and parasites, experts say.

Country / Region Tags:

General Topic Tags: